The druggable genome

  title={The druggable genome},
  author={A. Hopkins and C. Groom},
  journal={Nature Reviews Drug Discovery},
  • A. Hopkins, C. Groom
  • Published 2002
  • Biology, Medicine
  • Nature Reviews Drug Discovery
  • An assessment of the number of molecular targets that represent an opportunity for therapeutic intervention is crucial to the development of post-genomic research strategies within the pharmaceutical industry. Now that we know the size of the human genome, it is interesting to consider just how many molecular targets this opportunity represents. We start from the position that we understand the properties that are required for a good drug, and therefore must be able to understand what makes a… CONTINUE READING
    2,624 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    Targetability of human disease genes.
    • 36
    3.01 – Genomics
    Chapter 16 – Pharmacological Space
    Embryonic stem cells in drug discovery
    • J. McNeish
    • Biology, Medicine
    • Nature Reviews Drug Discovery
    • 2004
    • 173
    Genetic-Driven Druggable Target Identification and Validation.
    • 19
    Human monogenic disorders — a source of novel drug targets
    • 74
    Computational Strategies for Drug Reprofiling
    • 1
    • PDF


    In vivo drug target discovery: identifying the best targets from the genome.
    • 41
    Drug discovery: a historical perspective.
    • 2,213
    • PDF
    What If There Are Only 30,000 Human Genes?
    • 285
    • PDF
    The end of the beginning for genomic medicine
    • 27
    Metabolite profiling for plant functional genomics
    • 1,778
    • PDF
    Sequence the Human Genome
    • 5,295
    • PDF